Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Open-market buy Chief Business Officer bought 12,000 shares at $6.82 ($81,799)
  2. 4 Open-market buy Chief Financial Officer bought 3,067 shares at an average $7.27 ($22,286)
  3. 4 Derivatives Options or other derivatives
  4. 4 Gift CEO gave 20,000 shares (gift)
  5. 4 Open-market buy Chief Business Officer bought 30,000 shares at $12.31 ($369,300)
  6. 4 Open-market buy Chief Business Officer bought 22,539 shares at $8.85 ($199,470)
  7. 4 Open-market buy Director bought 2,000 shares at $10.44 ($20,880)
  8. 4 Open-market buy Chief Executive Officer bought 3,500 shares at $8.54 ($29,890)
  9. 4 Open-market buy Chief Technology Officer bought 3,796 shares at $10.40 ($39,478)
  10. 4 Open-market buy CCO and General Counsel bought 11,100 shares at $9.24 ($102,564)
  11. 4 Open-market buy Chief Financial Officer bought 1,416 shares at an average $8.91 ($12,610)
  12. 4 Open-market buy Chief Business Officer bought 22,539 shares at $8.85 ($199,470)
  13. 4/A Open-market buy Chief Operating Officer bought 5,000 shares at $20.50 ($102,500)
  14. 3/A Insider 3/A
  15. 3/A Insider 3/A
  16. 3/A Insider 3/A
  17. 4 Option exercise Director acquired 300,000 shares (option exercise)
  18. 4 Option exercise Former Chief Revenue Officer acquired 87,182 shares (option exercise)
  19. 4 Other acquisition Director acquired 1,200,000 shares (other)
  20. 4 Grant or award Director acquired 1,200,000 shares (grant or award)

Page 8 of 12 · 230 filings